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an anti-retroviral therapy programme in Makurdi,
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Emmanuel A Anígilájé1*†, Othniel J Dabit1, Ayodotun Olutola2†, Bem Ageda3 and Sunday A Aderibigbe4†Abstract
Background: In Nigeria, reports of the outcomes of prevention of mother to child transmission of HIV (PMTCT)
interventions had been limited to the MTCT rates of HIV, with no information on HIV-free survival (HFS) in the
HIV-exposed infants over time.
Methods: A retrospective study between June 2008 and December 2011 at the Federal Medical Centre, Makurdi,
Nigeria comparing HFS rates at 3 and 18 months according to the infant feeding pattern at the 6th week of life.
HFS was assessed by Kaplan-Meier analysis and association of maternal and infant variables and risk of HIV
acquisition or death was tested in a Cox regression analysis.
Results: 801 HIV uninfected infants at 6 weeks of life were studied in accordance with their reported cumulative
feeding pattern. This includes 196 infants on exclusive breast feeding (EBF); 544 on exclusive breast milk substitute
(EBMS) feeding and 61 on mixed feeding (MF). The overall HFS was 94.4% at 3 months and this declined significantly to
87.1% at the 18 months of age (p-value = 0.000). The infants on MF had the lowest HFS rates of 75.7% at 3 months and
69.8% at 18 months. The HFS rate for infants on EBF was 97.4% at 3 months and 92.5% at 18 month whilst infants on
EBMS had HFS of 99.1% at 3 months and 86.2% at 18 months. A higher and significant drop off in HFS at the two time
points occurred between infants on EBMS (12.9%) compared to infants on EBF (4.9%), p-value of 0.002, but not between
infants on MF (5.9%) and EBMS, p-value of 0.114 and those on MF and EBF, p-value of 0.758. In Cox regression
multivariate analyses; MF, gestational age of ˂ 37 weeks, and a high pre-delivery maternal viral load were consistently
associated with HIV infection or death at 3 months and 18 months (p ˂0.05).
Conclusion: For a better HFS in our setting; MF must be avoided, efforts to deliver babies at term in mothers with
reduced viral load are advocated and EBF must be promoted as the safest and the most feasible mode of infant-feeding.
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Among the few mothers that accessed prevention of
mother to child transmission of HIV (PMTCT) services
in Nigeria, the reports of successes in interventions had
been limited to stating the MTCT rates of HIV, indicat-
ing values in the range of 1.1%-11%, over 6 weeks to
18 months of age [1-5]. However, limited information* Correspondence: demolaanigilaje@yahoo.co.uk
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unless otherwise stated.exists on the longitudinal follow-up and survival of these
HIV-exposed infants.
In 2010, the World Health Organization (WHO)
proposed HIV-free survival as the gold standard for
evaluating National PMTCT programme effectiveness
[6]. HIV-free survival captures information on the direct
effects and the indirect effects of PMTCT programmes.
The direct effects include information on HIV infection
at birth and through breastfeeding and the deaths
prevented [6]. The indirect survival benefits that mayl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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infected are also important [6].
Breastfeeding provides immunity against diarrhoeal
disease and pneumonia, but these benefits have to be
balanced against the risk of HIV transmission via breast
milk [7,8]. Replacement feeding when exclusive is ex-
pected to prevent HIV transmission that occurs via
breast milk. However, in areas where water supply is un-
safe and poverty is rife, it increases infants’ mortality
from diarrhoea and malnutrition [9]. Therefore, the
WHO recommends replacement feeding as an alterna-
tive to breastfeeding only when it is affordable, feasible,
acceptable, safe and sustainable (AFASS) [10]. Unfortu-
nately, in Nigeria, the AFASS criteria are rarely met even
in programmes where Breast-Milk Substitutes (BMS) are
provided free of cost and mixed feeding is a common
practice [11,12]. Mixed feeding combines the risk of
HIV transmission through breastfeeding with the in-
creased risk of mortality associated with replacement
feeding [13,14].
Bearing the foregoing in mind and to the best of the
Authors’ knowledge, there is no study that has reported
the HIV-free survival rates in Nigerian HIV-exposed
infants.
Therefore, we conducted a retrospective study among
HIV-exposed babies delivered between June 2008 and
December 2011 and compared the cumulative HIV-free
survival rates at 3 and 18 months of life according to the
early infant feeding modalities at the 6th week of life.
Methods
Study area and setting
The study was carried out at the Paediatric antiretroviral
therapy (ART) Clinic of the Riverside Specialist Clinics
of the FMC, Makurdi. The facility is supported by the
AIDS Prevention Initiative in Nigeria (APIN)/Harvard
PEPFAR (The USA President’s Emergency Plan for AIDS
Relief ) programme.
Ethical consideration
Upon recruitment into the care and ART programme,
parents or caregivers of the HIV-exposed infants had
initially provided written informed consent for the use
of their data for research as approved by the Research
and Ethics Committee of the FMC, Makurdi and the
APIN/Harvard PEPFAR programme. For this study,
permission was sought for and gotten for the use of the
relevant data.
Study design and population
It was a retrospective study between June 2008 and
December 2011. Included were HIV-exposed uninfected
infants at 6 weeks that were delivered to HIV-infected
mothers who had received PMTCT interventions atFMC, Makurdi. Excluded were; (i) infants of HIV-
infected mothers who did not attend antenatal care at
FMC, Makurdi and whose mothers did not receive anti-
retroviral drugs (ARVs) for PMTCT;(ii) infants who had
received blood transfusion and or those with a proven
history of sexual abuse that may suggest horizontal
mode of HIV transmission; (iii) infants who were on
breastfeeding but whose mothers died before the 6th
week of life; (iv) the second of a set of twin; (v) infants
whose DNA/PCR results were equivocal (vi); and infants
whose DNA/PCR were positive at the 6th week of life
that may be suggestive of an in-utero or intra-partum
HIV transmission [15,16].
Follow-up of HIV positive pregnant mothers and their
infants and operational definitions
HIV-exposed infants were first seen within the first
24 hours of life and thereafter, every 2-week for the
first 6 weeks, every month for the first 3 months and
3-monthly till the age of 18 months. Early infant diagno-
ses with the DNA/PCR were offered routinely at the 6th
week and at the 3rd month of life and the HIV antibody
test at the 18th month when infants were then discon-
tinued from care when found to be HIV uninfected and
in optimal nutritional state. Infants found to be HIV-
infected at any point in time were promptly commenced
on highly active antiretroviral therapy (HAART) in
accordance with the clinical and age-dependent im-
munological criteria of WHO guideline of 2006 [17].
Infants were regarded as HIV-infected if two samples
were positive for HIV DNA/PCR and or there was a
positive HIV serology at 18 months. If HIV DNA/PCR
test was negative and or HIV serology was negative at
the 18 months, the infants were said to be HIV unin-
fected. Co-trimoxazole prophylaxis was given to all
infants from the 6th week of life. HIV infected women
who had been on HAART before conceptions were
counselled on optimal adherence to HAART throughout
the antenatal visits. PMTCT treatment guidelines for the
HIV-infected pregnant women also followed the 2006
WHO recommendations [17]. During the first ANC
visit, pregnant women whose HIV status were unknown
received HIV testing and counselling and those found
to be HIV-infected were screened for clinical and
immunological eligibility for the commencement of
HAART. Mothers who were eligible [i.e., having Cluster-
of- differentiation- 4 T lymphocytes (CD4) counts ˂ 200
cells/mm3] received HAART regimen including Zi-
dovudine (AZT) or Stavudine (d4T) plus Lamivudine
(3TC) plus Nevirapine (NVP). Women not eligible for
HAART had AZT from 28 weeks of gestation and were
given single-dose NVP and 3TC during labour and
delivery and also, a 7-day tail of 3TC and AZT postpar-
tum. HIV-exposed babies received a single dose of
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72 hours of life and also AZT given for 7 days. Babies
have option of being fed with either exclusive breast
milk substitutes feeding (EBMS) for the first 6 months
of life when AFASS or exclusive breastfeeding (EBF) for
the first 6 months of life in accordance with the Niger-
ian Guidelines for Paediatric HIV and AIDS Treatment
and Care of 2007 [18]. Mixed feeding was thoroughly
discouraged. Mothers received infant-feeding counsel-
ling during antenatal care and were allowed to make
informed choices on EBMS or EBF. For mothers who
opted for EBMS, they were taught on the hygienic tech-
nique of constituting the BMS using cooled boiled
water, stipulating the use of cups and discouraging
bottle-feeding. The programme provided a 6-month
(on a monthly discrete prescription) supply of free in-
fant formula to mothers who opted for EBMS. In order
to enhance the safety of EBMS, mothers also received
free Sodium hypochlorite (Water Guard®). Detailed
feeding histories were from maternal recalls.
For the purpose of this study, the cumulative feeding
pattern reported up to the 6th week of life was used to
group the infants. The definitions of EBF, EBMS
(Replacement feeding) and Mixed feeding (MF) were as
described previously [7,17,19]. Two episodes of in-
stances of mixed feeding were required for MF in this
study. Late-post-natal- HIV- transmission (PNT) was
assumed in infants who were DNA/PCR negative at
their 6-week visit but were DNA/PCR positive at the
3rd month or HIV serology positive subsequently. This
reflects HIV infection that is unequivocally attributable
to breastfeeding [7,15] having excluded infants with
horizontal HIV transmission and this was the focus of
this study.
Data collection
Data were from both electronic databases and Patients’
Record files of mother-infants pairs. Time-dependent
information such as; infants’ HIV status state (positive or
negative), infants that were Lost to follow-up, and the
Vital status state (dead or alive) were particularly sought
for cumulatively up to the 6th week, the 3rd month and
the 18th month of follow-up.
Measured outcome
Cumulative HIV- free survival rates at 3 and 18 months
of follow-up according to early infants’ feeding at 6 weeks
of life.
Statistical analysis
Statistical analysis was done using the SPSS version 16.
Characteristics were summarized using means and
medians for continuous variables and proportions for
categorical variables. The Mann–Whitney (two groups)and Kruskal-Wallis (three groups) tests were used for as-
sociation between and among the medians and unpaired
‘t’ test (two groups) and one-way ANOVA (three groups)
were used for the means. Pearson Chi-squared test or
Fischer’s exact test was used for categorical variables.
Cumulative HIV- free survival, HIV transmission and
Mortality at the 3rd and 18th month of life were
assessed by Kaplan-Meier analysis according to the
reported early infant feeding pattern (i.e. EBF, EBMS,
and Mixed) at the 6th week. Sample t-test between pro-
portions was used to test the decay in HFS rates between
EBF and EMBS over 3 to 18 months. Association of ma-
ternal and infant variables and risk of HIV acquisition or
death was tested in a Cox regression analysis. The model
included maternal and infant factors significant at p ≤
0.1 in Univariate analyses and a priori factors [16]-
maternal CD4 count and viral load, breast mastitis, low
birth weight, oral sores/oral thrush in the infants- for
MTCT regardless of their level of significance. The clin-
ical endpoints for calculating HIV-free survival included
time to HIV infection or time to death. The date of the
first event (either HIV infection or death if the child
experienced both events) was used as the event date.
Censoring for the HIV-free survival, HIV-infection and
mortality outcomes occurred due to loss –to- follow-up
at the visit when this was first noted. For all analyses,
confidence intervals (CI) were set at 95% level and p-
values less than 0.05 were considered statistically
significant.Results
Figure 1 is the schematic diagram of the follow-up of
the infants in the study. 855 infants were born alive to
HIV-infected mothers but only 801 infants who were
DNA/PCR negative at the 6th week were included in the
study. Reasons for the exclusion of the other 54 infants
were as shown in Figure 1. Among these 801 infants,
206 mothers had initially opted for EBF and 595 mothers
for EBMS within the first 24 hours of birth (i.e.,
intention -to -feed). However, by the 6th week of follow-
up, 61 infants were already mixed- fed. This included 10
of the initial exclusive breast-feeders (i.e., EBF uptake of
95.1%) and 51 of the initial replacement feeders (EBMS
uptake of 91.4%). Among the MF infants, the infant
feeds in addition to the mix of breast milk/BMS (43 in-
fants, 70.5%) were maize gruels in 12 infants, (19.6%, 12/
61) and cocoa beverages (Milo®) in 6 infants, (9.8%, 6/
61). At the 3rd month of life, after excluding infants that
were lost to follow-up and those that died, 94.9% (186/
196) of the infants were still on EBF, 95.8% of the infants
were still on EBMS, and 78.7% were still mix-feeding.
Same proportions were on these feeding patterns by the
6th month.
Figure 1 Schematic diagram of the follow-up of the infants in the study. Legends: LTFP: loss to follow up; EBF: exclusive breast feeding;
EBMS: exclusive breast milk substitute feeding; MF: mixed feeding; PMTCT; prevention of mother to child transmission of HIV.
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infants’ feeding pattern
Table 1 shows that out of the 801 infants, 401 were
males (M) and 400 were females (F) with a M; F ratio of
1: 0.99. Ninety four percent (751/801) of the mothers in
this cohort received HAART for their own HIV disease.
Most of these women (336/751, 44.7%) were on HAART
before pregnancy. Among the 415 mothers who initi-
ated HAART during pregnancy, 290 (38.6%) were
commenced during the first trimester while 25 (3.3%)
and 100 (13.3%) initiated HAART during the second
and the third trimester respectively. A significantnumber of mothers who opted for EBMS were prim-
iparous when compared with EBF alone (P value 0.008)
as well as when compared with infants on EBF and MF
(P value 0.04).
HIV-free survival, HIV-infection and infants’ mortality
according to the early infants’ feeding pattern
Table 2 shows that the overall cumulative HIV-free
survival rate was 94.4% at 3 months and this declined
significantly to 87.1% at the 18 months of age (p-value;
0.000). The 3 month cumulative HIV-free survival rates
for the EBF, the EBMS and the Mixed fed infants were
Table 1 Maternal and infant characteristics according to








Male 95 (48.5) 278 (51.1) 28 (45.9)
Female 101 (51.5) 266 (48.9) 33 (54.1)
Total number 196 544 61
Birth weight
Mean (SD) 2.91 (0.35) 2.88 (0.43) 2.86 (0.36)
˂2500 g 17 (8.7) 59 (10.8) 4 (6.6)
≥2500 g 179 (91.3) 485 (89.2) 57 (93.4)
Gestational age at
birth
˂37 weeks 5 (2.6) 21 (3.9) 2 (3.3)
≥37 weeks 191 (97.4) 523 (96.1) 59 (96.7)
Mode of delivery
Vaginal 189 (96.4) 513 (94.3) 59 (96.8)
EME C/S 6 (3.1) 27 (5.0) 1 (1.6)
ELE C/S 1 (0.5) 4 (0.7) 1 (1.6)
ROM
˂4 hours 182 (92.9) 507 (93.2) 57(93.4)
≥4 hours 13 (6.6) 33 (6.1) 3 (4.9)
No ROM 1(0.5) 4 (0.7) 1 (1.6)
Vaginal tear
Yes 50 (25.5) 133(20.8) 17 (27.9)
No 146 (74.5) 431 (79.2) 44 (72.1)
Infants’ oral thrush
Yes 3 (1.5) 10 (1.8) 3 (4.9)
No 193 (98.5) 534(98.2) 58 (95.1)
Infants’ oral sore
Yes 5 (2.6) 8 (1.5) 2 (3.3)
No 191 (97.4) 536 (98.5) 59 (96.7)
Mother’s age group
in years
Mean (SD) 28.8 (5.4) 29.0(5.4) 28.9(5.6)
15 – 24 38 (19.4) 99 (18.2) 13 (21.3)
25 - 34 133 (67.9) 360 (66.2) 40 (65.6)
35 - 39 21 (10.7) 71 (13.1) 5 (8.2)
≥40 4 (2.0) 14 (2.6) 3 (4.9)
*Mothers’ CD4 count
(Cell/mm3) 176 490 55
Median (IQR) 408 (335–537.8) 403 (316–557) 377 (286–505)
˂ 200 10 (5.1) 39 (7.2) 6 (9.8)
200 – 349 41 (20.9) 119 (21.9) 13 (21.3)
359 – 499 79 (40.3) 178 (32.7) 21 (34.4)
≥500 46 (23.5) 154 (28.3) 15 (24.6)
Table 1 Maternal and infant characteristics according to
the early (first 6 weeks) feeding pattern (Continued)
Missing 20 (10.2) 54 (9.9) 6 (9.8)
*Mothers’ viral load
(Copies/ml) 175 474 56
Median (IQR) 200 (200–2198) 200 (200–1468.8) 200 (200–2775)
˂ 1000 117(59.7) 328 (60.3) 39 (63.9)
1000 – 9999 33 (16.8) 95 (17.5) 9 (14.8)
10,000 – 99, 999 19 (9.7) 41 (7.5) 6 (9.8)
≥100, 000 6 (3.1) 10 (1.8) 2 (3.3)
Missing 21 (10.7) 70 (12.9) 5 (8.2)
^PMTCT Intervention
in the mother
HAART 188 (95.9) 505 (92.8) 58 (95.1)
ARV 8 (4.1) 39 (7.2) 3 4.9
*Mothers’
hemoglobin
˂10 g/dl 21 (10.7) 86 (15.8) 11 (18.0)
≥10 g/dl 175 (89.3) 458 (84.2) 50 (82.0)
§Mothers’ Parity
1 84(42.9) 263 (48.3) 28 (45.9)
2 – 4 81 (41.3) 237 (43.6) 28 (45.9)
≥5 31 (15.8) 44 8.1 5 8.2)
Mothers’ religion 188(95.9) 528 (97.1) 60 (98.4)






and the 6th month
Yes 4 (2.0) 14(2.6) 2 93.3)
No 196(98.0) 530 (97.4) 59 (96.7)
Mothers’ vital status at
18 month
Dead 2 (1.0) 5 (0.9) 0 (0)
Alive 194 (99.0) 539 (99.1) 61 (100)
Mothers’ level of
education
None 52 (26.5) 109 (20.0) 13 (21.3)
Primary 44 (22.4) 133 (24.4) 12 (19.7)
Secondary 97 (49.5) 296 (54.4) 36 (59.0)
Tertiary 3 (1.5) 6 (1.1) 0 (0)
Mothers’ marital
status
Without a partner 7 (3.6) 29 (5.3) 5 (8.2)
With a partner 189 (96.4) 515 (94.7) 56 (91.8)
Mothers/family
monthly income
149 (76.0) 409 (75.2) 52 (85.2)
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47 (24.0) 125 (24.8) 9 (14.8)
Legends: N = number; SD = standard deviation; IQR = interquartile range; EME
C/S = emergency caesarean section; ELE C/S = elective caesarean section;
EBF = exclusive breast feeding; EBMS = exclusive breast milk substitute
feeding; MF =mixed feeding; ROM= rupture of membrane; PMTCT = prevention
of mother to child transmission of HIV; USD = united states dollars;
* = pre-delivery values; ^= Most of these women (336) were already on
HAART before conception, 290 were commenced on HAART at the first
trimester and 25 and 100 mothers started HAART during the second and
the third trimester respectively;§ = significant p values exist among
primiparous women who opted for EBMS when compared with EBF alone
(P value 0.008) as well as when compared with infants on EBF and MF
(P value 0.04).
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son at the 3rd month for HIV-free survival rates
between EBF and EBMS infants was not significant at p-
value of 0.078 but was significant between EBF and MF
(p-value; 0.000) and between EBMS and MF (p value;
0.000). There was a fall in the cumulative HIV-free sur-
vival rates at 18 month from the 3rd month rates for all
the three feeding patterns with values for EBF, EBMS
and MF being 92.5%, 86.2% and 69.8% respectively.
When the rate of fall in HFS between the two time
points was compared between infants on EBF (97.4% to
92.5%, i.e. 4.9%) and those on EBMS (99.1% to 86.2%,
12.9%), a significant difference (p-value of 0.002) was
gotten. The rate of fall in HFS was however not signifi-
cant between infants on MF (75.7% to 69.8%, 5.9%) and
EBMS, p-value = 0.114 and between infants on MF and
EBF, p-value = 0.758.
By the 3rd month, HIV-infection had been confirmed
in 3 infants on EBF, 7 infants on MF but only in one
infant on EBMS, with significant cumulative late-post-
natal-HIV-infection rates of 1.5% (95% CI;0.004-2.99) in
EBF, 0.2% (95CI;0.014-0.414) in EBMS and 12.6% (95%
CI; 4.35-20.85) in MF groups. Pair-wise comparison re-
vealed that significant differences occurred in HIV infec-
tion rates between EBF and EBMS babies (p-value:
0.027) and between EBF and MF babies (p-value; 0.000)
and also between EBMS and MF infants (p-value; 0.000).
More HIV-infections occurred between the 3rd and
the 18th month. This included 11 infants on EBF, 20 in-
fants on EBMS and 13 infants on MF, with respective
significant cumulative Post-natal-HIV-infection rates of
7.0% (95%CI; 3.86-10.14), 4.3% (95%CI; 3.33-5.27), and
27.1% (95CI;16.05-38.15). Significantly more HIV infec-
tions occurred among MF infants when compared with
babies on EBF (p-value of 0.000) and among MF infants
when compared with EBMS infants (p = 0.000) but not
between EBF and EBMS infants (p = 0.237). Between the
3rd and the 18 months, the feeding pattern impactedsignificantly on HIV-infection rates for all the infant
feeding groups; the EBF infants (p = 0.007), the EBMS
infants (p = 0.000) and the MF infants (0.047).
The HIV-infection rates at 18 months were 3.73, 2.43
and 14.2 per child-year for the infants on EBF, EBMS
and MF respectively.
By the 3 months of life, no death was recorded among
EBF infants whereas 2 and 3 deaths were recorded
among EBMS and MF infants respectively. All the two
deaths in the EBMS infants were due to severe pneumo-
nia and for the MF group, the 3 deaths resulted from
diarrhoeal disease. Only one of the five infants that died
was HIV-infected. Kaplan Meier estimate of death was
only significant for EBMS infants at 0.4% (95%CI; 0.097-
0.703). However, by the 18th month of life, mortality
rates of 2.1% (95%CI; 1.41-2.79) occurred for EBMS
infants and 12.1% (95% CI; 3.99-20.21) for MF infants.
Two infants on EBF (diarrhoeal disease), 4 infants on
EBMS (2 from disseminated tuberculosis, 2 from severe
malaria) and 6 infants (2 from severe pneumonia and 4
from diarrhoeal disease) with MF had died. HIV-
infection was diagnosed in 5 (4 among MF and 1 of EBF
infants) of the 12 deaths (41.7%). More deaths occurred
between the 3 rd month and 18th month for the EBMS
infants, (p value 0.012).
Figure 2 is the HIV-free survival curves of the infants
according to the early infant feeding pattern.
Cox proportional regression model for risk of HIV
infection or death at 3 months and 18 months
Tables 3 and 4 reveal that in Cox regression multivariate
analyses, only infants that had MF, those born at gesta-
tional age of ˂ 37 weeks, and those whose mothers had
a high pre-delivery maternal viral load (10,000-99,999
copies/ml) were consistently associated with the risk of
HIV infection or death at 3 months and 18 months.
Mixed fed infants were 44 times more likely at 3 months
and 5 times more likely at 18 months. Infants born at
the gestational age of ˂ 37 weeks were 17 times more
likely at the 3rd month and 8 times more likely at
18 months. Lastly, mothers with a high viral load in the
range of 10,000-99,999 copies/ml were 10 times more
likely and twice more likely to have died or contract the
HIV infection at the 3rd month and the 18th month
respectively.
Discussion
HIV Free survival provides greater insight into the
efficiency of PMTCT programmes and helps influence
choice of interventions. Among the 801 HIV uninfected
infants at 6 weeks of life, the overall HFS was high at
94.4% at 3 months and 87.1% at the 18 months of age.
The HFS rates for the infants on EBF were particularly
impressive at the two time points even when ARVs were
Table 2 HIV-free survival, HIV-infection and infants’ mortality according to the early infants’ feeding pattern
Kaplan- Meier estimate at
the 3rd month % (95CI)
P value = between
EBF and EBMS
Kaplan- Meier estimate at
the 18th month %(95CI)
P value = between
EBF and EBMS
P value between HFS
rates at 3rd month
and 18th month
P value* = between
EBF and MIXED











EBF 97.4% (95.4 -99.4) 0.078 92.5% (89.26-95.74) 0.107 0.027
EBMS 99.1% (98.6- 99.6) *0.000 86.2% (84.55-87.85) *0.000 0.000
MF 75.7% (65.0 -86.4) ^0.000 69.8% (58.39-81.21) ^0.000 0.466
HIV-infection
EBF 1.5% (0.004 -2.99) 0.027 7.0% (3.86-10.14) 0.237 0.007
EBMS 0.2% (0.014-0.414) *0.000 4.3% (3.33-5.27) *0.000 0.000
MF 1.26% (4.35-20.85) ^0.000 27.1% (16.05-38.15) ^0.000 0.047
Death
EBF 0% (NA) 0.395 1.1% (−0.18-2.38) 0.567 0.142
EBMS 0.4% (0.092 – 0.703) *0.002 2.1% (1.41-2.79) *0.000 0.012
MF 4.9% (−0.47 -10.27) ^0.000 12.1 (3.99-20.21) ^0.000 0.157
Legends: HFS = HIV free survival; EBF = exclusive breast feeding; EBMS = exclusive breast milk substitute feeding; MF =mixed feeding; NA = not available. The rates
of fall in HFS over the 3rd and the 18th month was compared by sample t-test for proportions between infants on: EBF and EBMS, p-value =0.002, t-statistics = 3.096;
MF and EBMS, p-value = 0.114, t-statistics = 1.584; MF and EBF, p-value = 0.758, t-statistics = 0.309.
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prophylaxis through breastfeeding period. We propose
that, a higher HFS values are obtainable if ARVs had
been administered to these infants through breastfeed-
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Figure 2 HIV-free survival curves of the infants according to the early
EBMS: exclusive breast milk substitute feeding; MF: mixed feeding.the prolonged exposure of HIV-uninfected children to
unwarranted ARVs are contending issues. Infants that
were mix fed had the lowest HFS rates at 3 months and
18 months and thus contributed adversely to the overall
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EBF (Ref) 3 (20.0)
EBMS 3 (20.0) 0.209 0.368 (0.059 - 2.305) 0.286
MF 9 (60.0) 0.000 44.12 (5.574 - 349.214) 0.000
Birth weight (grams)
≥2500 (Ref) 15 (100.0)
˂2500 0 (0.0) 0.402 0.000 (0.000 - 0.000) 0.982
Gestational age
(weeks)
≥37 (Ref) 11 (78.3)
˂37 4 (26.7) 0.000 17.00 (1.817 – 159.083) 0.013
Mode of delivery
ELE C/S (Ref) 2 (13.3)
Vaginal 12 (80.0) 0.000 0.023 (0.000 – 1.271) 0.065
EME C/S 1 (6.7) 0.043 0.083 (0.001 – 7.157) 0.273
ROM
NO ROM (Ref) 2 (13.3)
˂4 hours 11 (73.3) 0.000 0.962 (0.085 – 10.835) 0.975
≥4 hours 2 (13.3) 0.029 NA NA
Vaginal tear
No (Ref) 8 (53.3)
Yes 7 (46.7) 0.031 2.309 (0.604 – 8.832) 0.221
Oral thrush
No (Ref) 14 (93.3)
Yes 1 (6.7) 0.0231 0.034 (0.000 – 2.952) 0.137
Oral sores
No (Ref) 15 (100.0)
Yes 0 (0.0) 0.719 0.000 (0.000 – 0.000) 0.990
Mothers’ age group in years
15-24 (Ref)
25-34 1 (6.7)
35-39 10 (66.7) 0.319 NA NA
≥40 3 (20.0) 0.178
1 (6.7) 0.155
*Mothers’ CD4 count (Cells/mm3)
≥500 (Ref) 3 (21.4)
˂200 3 (21.4) 0.329 1.592 (0.295 – 8.588) 0.588
200-349 2 (14.3) 0.499 0.359 (0.055 – 2.355) 0.286
350-499 6 (42.9) 0.093 0.139 (0.020 – 0.964) 0.046
*Mothers’ viral load (Copies/ml)
˂1000 (Ref) 7 (50.0)
1000-9999 2 (14.3) 0.998 1.421 (0.233 – 8.669) 0.703
10,000-99,999 5 (35.7) 0.004 10.68 (1.559 – 73.174) 0.016
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Table 3 Cox proportional regression model for risk of HIV infection or death at 3 months (Continued)
≥100,000 0 (0.0) 0.981 0.000 (0.000 – 0.000) 0.994
PMTCT intervention in the mother
HAART 3 (20.0)
ARV 12 (80.0) 0.036 0.639 (0.068 – 6.010) 0.695
*Mothers’ hemoglobin
≥10 g/dl (Ref) 3 (20.0)
˂10 g/dl 12 (80.0) 0.570 NA NA
Parity
1 (Ref) 3 (20.0)
2-4 9 (60.0) 0.075 3.107 (0.628 – 15.369) 0.165
≥5 3 (20.0) 0.056 4.378 (0.415 – 46.155) 0.219
Breast problems reported or diagnosed at any time
between birth and the 3rd month
No (Ref) 14 (93.3)
Yes 1 (6.7) 0.311 16.365 (1.359 – 197.091) 0.028
Mothers’ vital status at 3rd month
Alive (Ref) 15 (100.0)
Dead 0 (0.0) 0.814 0.000 (0.000 – 0.000) 0.997
Mothers’ level of education
Some (Ref) 10 (66.7)
None 5 33.3 0.274 NA NA
Mothers’ marital status
With a partner (Ref) 13 (86.7) 0.167 NA NA
Without a partner 3 (13.3)
Mothers/Family monthly income Minimum wage and
above (Ref)
Below minimum 1 (6.7)
wage (~105 USD) 14 (93.3) 0.150 NA NA
Legends: Ref = reference variable; EME C/S = emergency caesarean section; ELE C/S = elective caesarean section; EBF = exclusive breast feeding; EBMS = exclusive
breast milk substitute feeding; MF =mixed feeding; ROM = rupture of membrane; PMTCT = prevention of mother to child transmission of HIV; HAART = highly
active antiretroviral therapy; ARVs = antiretroviral prophylaxis; USD = United States dollars; * = pre-delivery values; NA = not available.
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infants on EBF at 18 months is comparable to the re-
ported HFS rates over 12–18 months in similar settings
in other countries where breastfeeding took place for up
to 6 months. Furthermore, the HFS rate of 92.5% was
better than the HFS rates of: 84.7% in Kenya [20]; 84.9%
in Botswana [21]; 86.4% in Tanzania [22] and 91.0% in
South Africa [23]; but lower than the HFS rates of 96%
in Cote d’Ivoire [24] and in Uganda [25].
In making comparison however, we are very cautious
of conclusive generalization because of differences in the
nature of our study and the designs of others [20-25].
The present study also reveals that infants who were
mix fed had a greater likelihood of dying or contracting
HIV infection at 3 months and at 18 months. In actual
fact, infants on MF were responsible for most deaths,
occurring majorly from diarrheal disease and severepneumonia. HIV-infection was also documented in most
of the dead mixed fed infants. Similar findings have been
reported earlier [13,14].
In addition, infants born at the gestational age of ˂
37 weeks were also found to be more at risk of HIV in-
fection or death at the two time points. Along with pre-
vious studies [26,27], our study also supports the fact
that preterm births may be associated with an increased
risk of HIV infection.
Furthermore, infants of mothers with a high pre-
delivery viral load (10,000-99,999 copies/ml) were more
likely to have HIV infection or died at the 3rd month and
at the 18th month. This finding is not unexpected as ma-
ternal viral load is a risk factor for post-natal HIV trans-
mission; with the plasma viral loads correlating positively
with the breast milk HIV viral loads and thus, a higher risk
of HIV transmission through breastfeeding [16].










EBF (Ref) 12 (23.5)
EBMS 24 (47.1) 0.148 0.382 (0.175 – 0.832) 0.015
MF 15 (29.4) 0.000 5.182 (2.273 – 11.809) 0.000
Birth weight (grams)
≥2500 (Ref) 47 (92.2)
˂2500 4 (7.8) 0.568 0.808 (0.273 – 2.397) 0.701
Gestational age (weeks)
≥37 (Ref) 41 (80.4)
˂37 10 (19.6) 0.000 8.084 (2.921 – 22.375) 0.000
Mode of delivery
ELE C/S (Ref) 2 (3.9)
Vaginal 46 (90.2) 0.032 0.447 (0.045 – 4.452) 0.492
EME C/S 3 (5.9) 0.243 0.977 (0.078 – 12.298) 0.986
ROM
NO ROM (Ref) 2 (3.9)
˂4 hours 40 (78.4) 0.022 0.637 (0.224 – 1.811) 0.398
≥4 hours 9 (17.6) 0.706 NA NA
Vaginal tear
No (Ref) 33 (64.7)
Yes 18 (35.3) 0.022 1.598 (0.820 – 3.113) 0.168
Oral thrush
No (Ref) 49 (96.1)
Yes 2 (3.9) 0.227 0.317 (0.043 – 2.338) 0.206
Oral sores
No (Ref) 50 (98.0)
Yes 1 (2.0) 0.857 3.015 (0.285 – 31.927) 0.359
Mothers’ age group in years
15-24 (Ref) 8 (16.7)
25-34 34 (66.7) 0.704 NA NA
35-39 8 (15.7) 0.364
≥40 1 (2.0) 0.837
*Mothers’ CD4 count
(Cells/mm3)
≥500 (Ref) 8 (16.7)
˂200 12 (25.0) 0.065 2.009 (0.683 – 5.904) 0.205
200-349 16 (33.3) 0.816 1.465 (0.596 – 3.600) 0.405
350-499 12 (25.0) 0.990 1.252 (0.544 – 2.883) 0.597
*Mothers’ viral load
(Copies/ml)
˂1000 (Ref) 25 (53.2) 0.265 1.468 (0.683 – 3.153) 0.325
1000-9999 10 (21.3) 0.001 2.526 (1.103 – 5.787) 0.028
10,000-99,999 11 (23.4) 0.864 0.617 (0.073 – 5.211) 0.658
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Table 4 Cox proportional regression model for risk of HIV infection or death at 18 months (Continued)
≥100,000 1 (2.1)
PMTCT intervention in the mother
HAART 6 (11.8)
ARVs 45 (88.2) 0.064 2.069 (0.784 – 5.460) 0.142
*Mothers’ hemoglobin
≥10 g/dl (Ref) 13 (25.6) 0.058 0.755 (0.332 – 1.718) 0.530
10 g/dl 38 (74.5)
Parity
1 (Ref) 24 (47.1)
2-4 22 (43.1) 0.942 NA NA
≥5 5 (9.8) 0.760
Breast problems reported or diagnosed at any time between birth
and the 18th month
No (Ref) 50 (98.0)
Yes 1 (2.0) 0.834 1.437 (0.187 – 11.203) 0.729
Mothers’ vital status at 18 month
Alive (Ref) 51 (100.0)
Dead 0 (0.0) 0.707 0.000 (0.000 – 0.000) 0.973
Mothers’ level of education NA NA
Some (Ref) 38 (74.5)
None 13 (25.5) 0.566
Mothers’ marital status
With a partner (Ref) 48 94.1 0.796 NA NA
Without a partner 1 (5.9)
Mothers/Family monthly income
Minimum and above wage (Ref) 12 (23.5)
Below minimum wage (~105 USD) 39 (76.5) 0.781 NA NA
Legends: Ref = reference variable; EME C/S = emergency caesarean section; ELE C/S = elective caesarean section; EBF = exclusive breast feeding; EBMS = exclusive
breast milk substitute feeding; MF =mixed feeding; ROM = rupture of membrane; PMTCT = prevention of mother to child transmission of HIV; HAART = highly
active antiretroviral therapy; ARVs = antiretroviral prophylaxis; USD = United States dollars; * = pre-delivery values; NA = not available.
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18th month of life, a respective late cumulative post-
natal-HIV-transmission rates of 0.2% and 4.3% occurred
among infants on EBMS. These findings have an import-
ant programmatic implication. It shows that, among
mothers who reported ‘EBMS’, the HIV transmission
seen in this group could only meant that these infants
had been breastfed and were therefore mixed fed. It im-
plies that even when infant formula and methods for
sterilising water were provided free of cost, mothers still
reverted to breastfeeding at some points in time and
therefore efforts at EBMS feeding is not feasible in our
setting and should be strongly discouraged.
Lastly, a higher and a significant drop off in HFS were
seen among EBMS infants (from the 3rd to the 18th
month) when compared to EBF. It shows that the appar-
ent higher HFS rate that was seen earlier among our
EBMS infants rapidly decayed over time and as early asthe 18th month of follow-up. This significant decline
further argues in favour of EBF over EBMS feeding.
Limitations of study
Although we have tried to eliminate the possibility of an
early post-natal- HIV transmission (occurring during
pregnancy and labour) via exclusion of babies that were
DNA/PCR positive at 6th week, on the other hand, a
reasonable window of late post-natal -HIV transmission
due to breast milk is actually possible from the 4th week.
We do not have a control over this possibility. Firstly,
this was a retrospective study and secondly, DNA/PCR
screening is only routinely done at the 6th week and the
3rd month of life of the HIV-exposed infants in our
ART programme protocol. Also, we were constrained to
classifying the infants into the feeding patterns at the
6th week, rather than at the 6th month of the expected
EBF or EBMS. We did this, so that we could take
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6th week as stated above. Also, the reported infants’
feeding pattern was by maternal recall and the possibility
of bias is high. Regardless of these limitations, our study
had a consistency in the feeding practice in accordance
with a WHO guideline [10]. Secondly, the decision to
breastfeed exclusively or not was not associated with
some maternal and infants indicators of health as there
were no significant differences (except for parity) in
these variables between the feeding patterns. Rather, the
choices in the feeding pattern (either EBF or EBMS) may
have been informed by the pre-delivery counselling
sessions that the mothers had during antenatal care.Conclusion
This study indicates that HIV-free survival rate was im-
pressive and comparable for infants on EBF and EBMS
at 3 months and at 18 months of life. It shows that MF,
preterm deliveries and a high pre-delivery maternal viral
load were consistently associated with a higher likeli-
hood of infants’ death or HIV acquisition at 3 months
and 18 months of follow-up. However, BMS feeding was
associated with a significant drop off in HFS rate over
time and babies on BMS reverted to MF. More also, in
most African countries, when and where BMS is pro-
vided free, its sustainability depends on the generosity of
the PMTCT Implementers which often, may not be pre-
dictable. For example, the free supply of EBMS offered
to mothers in our programme came to an abrupt end in
August 2011.
The 2010 WHO [28] recommendation still advocates
that mothers known to be HIV-infected can give infant
formula to their HIV uninfected infants or infants of an
unknown status, when AFASS are met; our study has
clearly shown that even when these infant formula are
provided free of cost and efforts at safety preparation of
this infant formula attempted, mothers still mixed fed
their babies by engaging in breastfeeding. We therefore
strongly recommend that EBF is the most feasible, most
practicable and the safest mode of infant feeding within
the context of HIV infection in our setting.Competing interests
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